No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Benzamides
-
Gastrointestinal Neoplasms / drug therapy
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Mutation / genetics
-
Neoplasms / drug therapy*
-
Neoplasms / genetics
-
Piperazines / therapeutic use*
-
Protein-Tyrosine Kinases / drug effects
-
Protein-Tyrosine Kinases / genetics
-
Pyrimidines / therapeutic use*
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate
-
Protein-Tyrosine Kinases